Phase II Trial of Neoadjuvant Pembrolizumab for Patients With Early Stage Gastroesophageal Adenocarcinoma
Clinical trial NCT04089904 · TERMINATED
Trial details
- NCT number
- NCT04089904
- Sponsor
- University of Chicago
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-11
- Primary completion
- 2023-03-11
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.